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were the duplex findings associated with reintervention? I
think a PSV value of 300 cm/s would be a reasonable criterion
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Dr Dennis Bandyk (San Diego, Calif). The Wake Forest
University vascular group suggests that renal duplex ultrasound
testing immediately following renal artery stent angioplasty can
predict the development of restenosis. But, is that the intent of
early duplex testing? The technical result of renal artery angioplasty
should be assessed by angiography, pressure-gradient measure-
ments, but also, by duplex ultrasound.
The authors chose to use peak systolic velocity 180 cm/s in
the stented segment as the criteria for restenosis. The study group
consisted of 92 treated arteries in 84 patients – 10 sites with a PSV
 180 cm/s were excluded. Only one-half of patients treated were
included in the duplex outcome analysis; an important limitation
of this study.
When an early (1 week) duplex testing was performed on
“technically successful” renal angioplasty sites; 10% demonstrated
elevated velocity of a residual stenosis; and in the remainder, PSV
velocity was increased in 38% of patients to indicate a restenosis had
developed. Development of restenosis correlated with elevated
preprocedure creatinine and the absence of bilateral disease, and
the authors concluded a PSV of 107 cm/s or greater predicted the
development of restenosis. I was not convinced by these findings
despite my bias that duplex surveillance after angioplasty is of
value: to exclude residual stenosis and identify hemodynamic fail-
ure of the angioplasty procedure.
My questions to the authors are:
(1) Did early duplex testing predict reintervention, and if so, whatfor significant restenosis – how often did a renal stent stenosis
of this severity occur?
2) Why exclude angioplasty sites with modest PSV elevation (ie,
250 cm/s)? In the 10 stents with a PSV 180 cm/s, how
many progressed and required reintervention?
3) Lastly, how do the authors suggest we use this information?
The authors have demonstrated a trend, but the predictive
value of their recommended duplex criteria is weak.
Dr Jason W. Christie. I will start with your last question first
egarding how to use the value of 107 cm/s, which is the optimal
utoff value on the ROC curve for predicting restenosis. Using that
alue to guide surveillance is not necessarily what we are proposing.
e were not proposing that velocity be used to help determine
hat you should do differently down the road in terms of surveil-
ance but rather to use that velocity to determine what you should
o differently at the time of the procedure. That could be repeating
n angioplasty or inserting IVUS to see if there is some other
echnical failure that is not evident on the traditional measures of
uccess such as digital subtraction angiography or intra-arterial
ressure measurements. Therefore, that is what that number
ould guide. In terms of the criteria for reintervention, we do not
se a specific duplex value to determine whether or not someone
ndergoes a reintervention. That is part of it, but then we only
eintervene if they have a physiologically significant restenosis with
schemic nephropathy or severe hypertension and if they derived a
enefit from the original intervention.
